Clinical Trials in Miami

Showing 3821-3840 of 11,431 trials

Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

NCT06129409

This trial is a Randomized, Double-Blind (Sponsor-Open), Placebo-Controlled Study to Assess the Effect of NT-0796 on Inflammation in Obese Participants at Risk of Cardiovascular Disease. Participants will be admitted to an in-patient Clinical Research Unit on Day -1 and will be discharged on Day 30. The trial will include a 7-day out-patient safety follow-up period following the last dose of study treatment. For the first approximately 20 participants effect of food will be evaluated on the Pharmacokinetics of NT-0796. MRI's will be conducted in a subset of participants.

Cardiovascular Diseases

NodThera Limited67 participantsStarted Oct 2023

Miami, Florida, United States • Austin, Texas, United States

COMPLETEDPhase 2< 1 mile

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

NCT05459688

This is a Phase 2, multicenter, open-label extension (OLE) study to evaluate the long-term safety, tolerability, and effectiveness of CIN-107 for up to 52 weeks in patients with HTN who have completed Part 1 or Part 2 of Study CIN-107-124. The study will be conducted at clinical sites that have participated in the double-blind, Phase 2 Study CIN-107-124.

Hypertension

AstraZeneca175 participantsStarted Apr 2022

Saraland, Alabama, United States • Huntington Park, California, United States • Lincoln, California, United States +33 more locations

Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Find Trials by Condition in Miami

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

Virtual Reality Technology for Vasectomy Pain Modulation

Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

The Impact of Respiratory Muscle Training and Patient Education on Chronic Constipation Outcomes

A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Study of ATH434 in Participants with Multiple System Atrophy

Risk of Recurrent CeAD After Pregnancy

Nitrous Oxide for the Treatment of Major Depressive Disorder